Panitumumab After Resection of Liver Metastases From Colorectal Cancer in KRAS Wild-type Patients

NCT01384994 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

111

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer
KRAS Wildtype
After Resection of Liver Metastases

Interventions

DRUG: Folic Acid
DRUG: 5-FU
DRUG: 5-FU
DRUG: Oxaliplatin
DRUG: Panitumumab
DRUG: Panitumumab
DRUG: Folic Acid
DRUG: 5-FU
DRUG: 5-FU
DRUG: Oxaliplatin

Sponsor

PD Dr. med. Volker Heinemann

Collaborators

[object Object]